Showing 2231-2240 of 3132 results for "".
- Alastin Receives Two New Patents for Technology Related to TransFORM Body Treatmenthttps://modernaesthetics.com/news/alastin-receives-two-new-patents-for-technology-related-to-transform-body-treatment/2473148/With the issuance of two new patents from the United States Patent and Trademark Office, Alastin Skincare, Inc. now holds six patents in the US, along with a seventh patent issued in Canada. US Patent No.11,052,032 covers Alastin’s
- New Hydrafacial, Epicutis Collab: Epicutis’ Neck & Décoletté Boosterhttps://modernaesthetics.com/news/new-hydrafacial-epicutis-collab-epicutis-neck-decolette-booster/2473144/HydraFacial is partnering with Epicutis to offer a new booster: Epicutis’ Neck & Décoletté Booster. Epicutis’ Neck & Décoletté Booster aims to reduce the wrinkled appearance of the face and neck, combat the appearance of fine lines and wri
- It’s Over: AbbVie, BTL Settle Muscle Stimulation Patent Disputehttps://modernaesthetics.com/news/its-over-abbvie-btl-settle-patent-dispute/2473143/BTL Industries has resolved its patent infringement claims against AbbVie related to BTL's muscle stimulation technology. Under the terms of the settlement agreement, AbbVie will pay BTL an undisclosed payment. The details of the agreement are confidential and will not be disc
- Sientra’s Allox2 Helps Manage Seroma and Infection in Prepectoral Breast Reconstructionhttps://modernaesthetics.com/news/sientras-allox2s-helps-manage-seroma-and-infection-in-prepectoral-breast-reconstruction/2473138/The Sientra Allox2 dual port tissue expander enables efficient management of seroma and early targeted intervention in prepectoral breast reconstruction, according to a new study on PRS Global Open. Seroma are among the most common complications after staged prepectoral implant
- As Aging Population Increases, Medical Aesthetics Market is Predicted to Growhttps://modernaesthetics.com/news/as-aging-population-increases-medical-aesthetics-market-is-predicted-to-grow/2473135/The global Medical Aesthetics Market, valued at USD 10.1 billion in 2018, is expected to reach USD 20.4 billion in 2026, growing at a CAGR of 9.0% during the forecast period, according to the latest report from All
- Study Tracks Increased Sadness, Fear, Disgust Among Healthcare Workers Linked to COVID-19https://modernaesthetics.com/news/study-tracks-increased-sadness-fear-disgust-among-healthcare-workers-linked-to-covid-19/2473134/Researchers discovered patterns of significantly decreased joy, increased sadness, fear and disgust among health care professionals (HCP) during the COVID-19 pandemic. The study, led by researchers at Ben-Gurion University of the
- Alma Introduces Women's Treatment for Alma Duohttps://modernaesthetics.com/news/alma-introduces-female-treatment-for-alma-duo/2473127/Alma is launching a new women's treatment for Alma Duo™. This new treatment protocol uses focused low-intensity extracorporeal shock wave therapy (LI-ESWT) to stimulate blood flow and help increase pleasure for women. Alma Duo, wh
- Alma Hybrid Launcheshttps://modernaesthetics.com/news/alma-hybrid-launches/2473128/Alma Hybrid™, the first laser platform to include an ablative 10,600nm (CO2) laser and a non-ablative 1570nm laser for skin resurfacing, in launching in the US. The system received FDA 510(k) clearance. Alma Hybrid offers p
- Alastin: New Study Supports Benefits of TransFORM Body Treatmenthttps://modernaesthetics.com/news/alastin-new-study-supports-benefits-of-transform-body-treatment/2473123/A clinical study and scientific article in The Aesthetic Surgery Journal (ASJ) highlights the beneficial results of daily use of TransFORM Body Treatment with TriHex Technology® (TransFORM) from Alastin Skincare. The Alastin
- Mentor Joins the ASPIRE Galderma Rewards Programhttps://modernaesthetics.com/news/mentor-joins-the-aspire-galderma-rewards-program/2473122/Mentor is joining Galderma as the first external collaborator for the ASPIRE Galderma Rewards Program. Now when patients choose qualifying Mentor Breast Implants, they’ll earn ASPIRE points that can be redeemed for savings on future Galderma treatments. Patients will al